Johnson & Johnson appears to exit LAA closure market, selling heart tech to new startup - Cardiovascular Business

Johnson & Johnson Exits LAA Closure Market, Selling Heart Tech to Startup

Cardiovascular Business reports that Johnson & Johnson appears to be exiting the LAA (Left Atrial Appendage) closure market, selling its heart technology to a new startup.